... Feb 18
23rd edition of Asia’s flagship life sciences forum on AI, automation and next wave of healthcare innovation opens in the city. ... Feb 17
Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health.... Feb 05
Sanofi India Limited (SIL) today announced that its Board of Directors, on the recommendation of the Nomination and Remuneration Committee, has appointed Deepak Arora as ... Oct 27
A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage ... Mar 26
Sanofi continues to give fresh impetus to its business in the Country with an accelerated growth plan - ‘India for India’, across its pharmaceuticals, specialty, consumer ... Mar 13
Latest pharma news updates... Nov 12
Latest pharma news update... Sep 20
Corporate Pharma news upedat... Aug 05
Fifth disease that Dupixent has demonstrated positive pivotal results.... Jul 29
Latest pharma update : Research and Collaboration... Jul 17
Latest FDA approvals update... Jul 16
As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources ... Jul 14
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a ... Jul 09
Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise... Jun 22
The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
... Jun 11
Moderna and Sanofi collaborate for covid vaccine manufacturing... Apr 28
GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)... Mar 18
It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO ... Feb 15
KY1005 binds to OX40-Ligand and has the potential to treat a wide variety of immune-mediated diseases and inflammatory disorders.... Jan 13
Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics... Jan 11
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
-Advertisements-
.jpeg)
Wednesday, August 05, 2026
.jpeg)
_11zon.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)